Prognosis in cardiogenic shock after acute myocardial infarction in the intervencional era

Journal of the American College of Cardiology

Volumn 20, Issue 7, 1992, Pages 1482-1489

  Bengtson, James R ^a   Kaplan, Andrew J ^a   Pieper, Karen S ^a   Wildermann, Nancy M ^a   Mark, Daniel B ^a   Pryor, David B ^a   Phillips III, Harry R ^a   Califf, Robert M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; AMRINONE; DOBUTAMINE; FIBRINOLYTIC AGENT; HYPERTENSIVE FACTOR; NORADRENALIN; STREPTOKINASE; UROKINASE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CARDIOGENIC SHOCK; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

ACADEMIC MEDICAL CENTERS; AGE FACTORS; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIAC OUTPUT; CARDIOTONIC AGENTS; COMBINED MODALITY THERAPY; CORONARY ANGIOGRAPHY; CREATINE KINASE; DECISION TREES; FEMALE; FOLLOW-UP STUDIES; HEART CATHETERIZATION; HOSPITAL MORTALITY; HUMAN; INTRA-AORTIC BALLOON PUMPING; ISOENZYMES; LOGISTIC MODELS; MALE; MIDDLE AGE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; NORTH CAROLINA; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SHOCK, CARDIOGENIC; STROKE VOLUME; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; SURVIVAL ANALYSIS; THROMBOLYTIC THERAPY; TREATMENT OUTCOME; VASOCONSTRICTOR AGENTS;

EID: 0027096467     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(92)90440-X     Document Type: Article

References (46)

1. Shock after acute myocardial infarction: a clinical and hemodynamic profile
2. Power failure in acute myocardial inferction
3. Pathophysiology and management of caidiogenic shock
4. Evaluation of therapy in shock following acute myocardial infarction
5. Treatment of myocardial infarction in a coronary care unit: a two year experience with 250 patients
6. Cardiogenic shock
7. The in-hospital development of cardiogenic shock after myocardial infarction incidence predictors of occurrence outcome and prognostic factors
8. Myocardial changes associated with cardiogenic shock
9. Progressive nature of myocardial injury in selected patients with cardiogenic shcek
10. Prevention of cardiogenic shock
11. Coronary perfusion during acute myocardial infarction with a combined therapy of coronary angioplasty and high-dose intravenous streptokinase
12. Coronary angioplasty therapy of cardiogenic shock complicating acute myocardial infarction (abstr)
13. A new information system for medical practice
14. Outcome in medically treated coronary artery disease
15. Estimation of the probability of an event as a function of several independent variables
16. The LOGIST procedure
17. Nonparametric estimation from incomplete observations
18. Regression models and life tables (with discussion)
19. Risk stratification for 1 year survival based on characteristics identified in the early hours of acute myocardial infarction: the Western Washington intracoronary streptokinase trial
20. Six- and twelve-month follow-up of the Phase I Thrombolysis in Myocardial Infarction (TIMI) trial
21. Improved survival up to four years after early coronary thrombolysis
22. Intraaortic balloon counterpwsalion with and without reperfusion for myocardial infarction shock
23. Percutaneous transluminal coronary angioplasly improves survival in acute myocardial infarction complicated by cardiogenic shock
24. Treatment of myocardial infarction in a communily hospital coronary car unit: experience with 1246 patients
25. Intraaortic balloon pumping in the treatment of cardiogenic shock complicating acute myocardial infarction
26. Coronary artery disease in patients dying from cardiogenic shock or congestive heart failure in the setting of acute myocardial infarction
27. Myocardial infarct size and cardiogenic shock
28. Cardiogenic shock
29. Quantitative study of infarcted myocardium in cardiogenic shock
30. Cardiogenic shock: myocardial morphology with and without artiticial left ventricular counterpulsation
31. Pathophysiology of cardiogenic shock: quantification of myocardial necrosis, clinical, pathologic, and electrocardiographic correlations
32. Use of drugs in cardiogenic shock due to acute myocardial infarction
33. Effectiveness of intiaaortic balloon pumping without cardiac surgery for patients with severe heart failure secondary to a recent myocardial infarction
34. Clinical and hemodynamic results of intraaortic balloon pumping and surgery for cardiogenic shock
35. Intraaortic balloon pump counterpulsation in cardiogenic shock: report of a cooperative clinical trial
36. Intraaortic balloon counterpulsalion in patients in cardiogenic shock medically retractory left ventricular failure and/or recurrent ventricular tachycardia
37. Treatment of cardiogenic shock in myocardial infarction by intrauortic balloon counterptilsation and surgery
38. Acute myocardial infarction treated with inlracaronary streptokinase: a report of the Society for Cardiac Angiography
39. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction
40. Cardiogenic shock in evolving myocardial infarction: treatment by angioplasty and Creptokinase
41. Hospital mortality of patients undergoing emergency angioplasty for acute myocardial infarction: relationship of mortality to cardiogenic shock and unsuccessful angioplasty (abstr)
42. Multicenter Registry of Angioplasty Therapy of Cardiogenic Shock: initial and long-term survival
43. Implications for patient triage from survival and left ventricular functional recovery analyses in 500 patients treated with coronary angioplasty for acute myocardial infarction
44. Hemodynamic evaluation of left ventricular function in shock complicating myocardial infarction
45. Recent changes in attack and survival rates of acute myocardial infarction (1975 through 1981)
46. Intraaortic balloon assistance in intractable cardiogenic shock